Acetazolamide (AZM)
Acetazolamide is a carbonic anhydrase inhibitor that is used for the medical treatment of glaucoma, epileptic seizure, idiopathic intracranial hypertension, altitude sickness, cystinuria, periodic paralysis, central sleep apnea, and dural ectasia. Acetazolamide is a carbonic anhydrase inhibitor. It can be used for the medical treatment of moderate to severe metabolic or respiratory alkalosis. Acetazolamide does this by interfering with bicarbonate (HCO3-) reabsorption in the kidneys, thereby reacidifying the blood – hence alkalyzing the urine. Acetazolamide has been used for the treatment of sufferers of glaucoma. When used to treat glaucoma, acetazolamide inhibits production of HCO3-. Normally, it is the production of HCO3- which draws Na+ into the eye; water follows by osmosis to form the aqueous humour. Acetazolamide is often used in the treatment of various diseases.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Acetazolamide (AZM) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Acetazolamide (AZM) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Acetazolamide (AZM) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Acetazolamide (AZM) CLIA Kit Customized Service Offer
n/a ELISA Kit for Acetazolamide (AZM) ELISA Kit Customized Service Offer